Show simple item record

dc.contributor.authorBüller, Harry R.
dc.contributor.authorGallus, Alex S.
dc.contributor.authorPillion, Gerard
dc.contributor.authorPrins, Martin H.
dc.contributor.authorRaskob, Gary E.
dc.contributor.authorLondoño Trujillo, Dario
dc.contributor.authorCassiopea Investigators
dc.date.accessioned2020-05-05T19:31:45Z
dc.date.accessioned2023-05-11T17:29:38Z
dc.date.available2020-05-05T19:31:45Z
dc.date.available2023-05-11T17:29:38Z
dc.date.created2012
dc.identifierhttps://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0140673611615055.pdf?locale=es_ES&searchIndex=spa
dc.identifier.issn0140-6736 / 1474-547X (Electrónico)spa
dc.identifier.urihttps://hdl.handle.net/20.500.12032/109192
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.languagespaspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.sourceLancet; Vol. 379 Núm. 9811 (2012)spa
dc.titleEnoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trialspa
dc.typeinfo:eu-repo/semantics/article


Files in this item

FilesSizeFormatView
1-s2.0-S0140673611615055.pdf265.5Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/

© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP